VERO Biotech

Transforming The Delivery of Inhaled Nitric Oxide

General Information
Company Name
VERO Biotech
Founded Year
2006
Location (Offices)
Atlanta, United States +1
Founders / Decision Makers
Number of Employees
213
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown
Social Media

VERO Biotech - Company Profile

VERO Biotech is an emerging biotechnology company founded in 2006, with a focus on designing, developing, and commercializing next-generation inhaled nitric oxide (NO) delivery systems. The company's slogan "Transforming The Delivery of Inhaled Nitric Oxide" encapsulates its mission to address unmet medical needs of patients with cardiopulmonary conditions. Based in the United States, Vero Biotech is committed to enhancing the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is necessary.

With its recent $30.00M Venture Round investment on 11 January 2023 from Petrichor Healthcare, Vero Biotech has attracted the attention of investors in the Biotechnology, Health Care, and Pharmaceutical industries. The company's dedication to exceeding customer expectations in terms of safety, efficacy, and growth, by focusing on the science, development, and commercialization of their innovations, signals a promising future for those considering investment opportunities in the biotechnology sector.

Taxonomy: inhalation therapy, nitric oxide, cardiopulmonary conditions, drug delivery systems, acute care, pulmonary diseases, cardiac diseases, innovation, clinical solutions, pharmaceuticals

Funding Rounds & Investors of VERO Biotech (7)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $30.00M 1 Petrichor Healthcare Capital Management 11 Jan 2023
Series E $100.00M 1 MVM Life Science Partners 21 Dec 2021
Debt Financing $50.00M 1 20 Jan 2021
Venture Round $29.94M - 29 Sep 2017
Private Equity Round $14.57M - 03 Oct 2013

View All 7 Funding Rounds

Latest News of VERO Biotech

View All

No recent news or press coverage available for VERO Biotech.

Similar Companies to VERO Biotech

View All
Third Pole Therapeutics - Similar company to VERO Biotech
Third Pole Therapeutics Transformative Cardiopulmonary Therapy
Nicox - Similar company to VERO Biotech
Nicox Maintain vision and improve ocular health
Pulmocide - Similar company to VERO Biotech
Pulmocide Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory diseases.
Corridor Pharmaceuticals, Inc. - Similar company to VERO Biotech
Corridor Pharmaceuticals, Inc. Pioneering the development and commercialization of therapeutic inhibitors to combat hyperplasia and fibrosis through innovative small molecule therapies.
Corus Pharma - Similar company to VERO Biotech
Corus Pharma Driving advancements in respiratory health with innovative inhalable treatments.